TMTakayuki Matsumoto

Takayuki Matsumoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takayuki Matsumoto has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Akira Madarame

    Department of Gastroenterology and Hepatology Tokyo Medical University Hospital Tokyo Japan

    1 shared publication
  • Daiki Nemoto

    Department of Gastroenterology and Hepatology Tokyo Medical University Hospital Tokyo Japan

    1 shared publication
  • Fumie Ikeda

    Department of Medicine and Clinical Science Graduate School of Medical Sciences Kyushu University 3-1-1 Maidashi Higashi-ku 812-8582 Fukuoka City Japan

    1 shared publication
  • Hayato Yamaguchi

    Department of Gastroenterology and Hepatology Tokyo Medical University Hospital Tokyo Japan

    1 shared publication
  • Hiroyuki Aikawa

    Department of Gastroenterology and Hepatology Niizashiki Central General Hospital Saitama Japan

    1 shared publication
  • Jun Hata

    Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

    1 shared publication

Latest Publications

  • Underwater endoscopic submucosal dissection for colorectal tumors decreases the incidence of post‐electrocoagulation syndrome

    by Yohei Koyama, Masakatsu Fukuzawa, Hiroyuki Aikawa, Daiki Nemoto, Takahiro Muramatsu, Taisuke Matsumoto, Kumiko Uchida, Akira Madarame, Takashi Morise, Hayato Yamaguchi, et al.

    Background and Aims: Underwater endoscopic submucosal dissection (U‐ESD) is a recently developed procedure that has the potential to prevent post‐ESD coagulation syndrome (PECS) owing to its heat‐sink effect. We aimed to clarify whether U‐ESD decreases the incidence of PECS compared with conventional ESD (C‐ESD).Methods: A total of 205 patients who underwent colorectal ESD (C‐ESD: 125; U‐ESD: 80) were analyzed. Propensity score matching analysis was performed to adjust for patient backgrounds. Ten C‐ESD and two U‐ESD patients with muscle damage or perforation during ESD were excluded when comparing PECS. The primary outcome was to compare the incidence of PECS between the U‐ESD and C‐ESD groups (54 matched pairs). Secondary outcomes were to compare procedural outcomes between the C‐ESD and U‐ESD groups (62 matched pairs).Results: Among the 78 patients who underwent U‐ESD, PECS occurred in only one patient (1.3%). Adjusted comparisons between the U‐ESD and C‐ESD groups demonstrated a significantly lower incidence of PECS in the U‐ESD group (0% vs 11.1%; P = 0.027). Median dissection speed was significantly faster in the U‐ESD than in the C‐ESD group (10.9 mm2/min vs 6.9 mm2/min; P < 0.001). En bloc and complete resection rates were 100% in the U‐ESD group. Although perforation and delayed bleeding occurred in one patient each (1.6%) as adverse events in the U‐ESD group, there were no differences compared with the C‐ESD group.Conclusions: Our study demonstrates that U‐ESD effectively decreases the incidence of PECS and is a faster and safer method for colorectal ESD.


  • Open Access

    White Blood Cell Count and Risk of Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study

    by M. Iida, Fumie Ikeda, Toshiharu Ninomiya, Koji Yonemoto, Yasufumi Doi, Jun Hata, Takayuki Matsumoto, Yutaka Kiyohara

    The authors examined the association between white blood cell (WBC) count and the development of gastric cancer in a 19-year follow-up study of 2,558 Japanese subjects aged ≥40 years (1988–2007). The subjects were stratified into 4 groups according to baseline WBC quartile (≤4.4, 4.5–5.2, 5.3–6.3, or ≥6.4 × 103 cells/μL). During follow-up, 128 subjects developed gastric cancer. The age- and sex-adjusted incidence of gastric cancer increased linearly with higher WBC level: 1.7, 2.6, 3.9, and 5.4 per 1,000 person-years, respectively, for the 4 quartile groups (P for trend < 0.01). The risk of gastric cancer was 2.22-fold (95% confidence interval: 1.19, 4.14) higher in the highest WBC quartile group than in the lowest group after adjustment for confounding factors. With respect to Helicobacter pylori infection status, H. pylori-seropositive subjects in the highest WBC quartile group showed a significantly greater risk of gastric cancer than those in the lower 3 quartile groups, whereas such an association was not observed in H. pylori-seronegative subjects. There was no evidence of heterogeneity in the association (P for heterogeneity = 0.65). The study findings suggest that higher WBC levels are a risk factor for gastric cancer, especially in subjects with H. pylori infection.